Picture of Iconic Labs logo

ICON Iconic Labs News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer CyclicalsHighly SpeculativeMicro CapSucker Stock

REG - Iconic Labs PLC - Conversion of Notes and Allotment of Shares

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250528:nRSb4885Ka&default-theme=true

RNS Number : 4885K  Iconic Labs PLC  28 May 2025

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Conversion of Notes and Allotment of Shares

Iconic Labs PLC (LSE:ICON), announces that it has received a valid Conversion
Notice from David Sefton.

The Conversion Notice was dated 28 May 2025 and provides for 1 Convertible
Note to be converted into 195,312 ordinary shares of £0.0001 in the Company
("Ordinary Shares") at a conversion price of GBP 0.0256 at the aggregate
principal amount of £5,000.

Application is therefore being made for an aggregate of 195,312 new Ordinary
Shares to be admitted to trading on the Main Market of the London Stock
Exchange which is expected to be on or around 3 June 2025. These shares rank
pari passu with the existing Ordinary Shares of the Company.

Following the issue of these shares, the Company's issued ordinary share
capital shall consist of 11,356,795 Ordinary Shares. The figure
of 11,356,795 represents the total voting rights in the Company and should be
used by shareholders as the denominator for the calculation by which they can
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance & Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

For any further information or enquiries please contact:

 

 Iconic Labs                                         via Yellow Jersey PR

 John Farquharson, Interim Chief Executive Officer
 Novum Securities Limited                            Tel: +44 (0) 20 7399 9400

 David Coffman / Daniel Harris
 Yellow Jersey PR                                    Tel: +44 (0) 20 3004 9512

 Charles Goodwin

 Annabelle Wills                                     iconic@yellowjerseypr.com

 Bessie Elliot

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CONAPMFTMTTTBMA

Recent news on Iconic Labs

See all news